Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty: A Prospective, Randomized Trial

NCT05297305 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT05297305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05297305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty: A Prospective, Randomized Trial
Lead sponsor
Corewell Health East
Phase
Not applicable
Overall status
Terminated
Start date
October 20, 2023
Completion date
November 24, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis shoulder, rotator cuff injuries